Ignite Creation Date:
2024-05-06 @ 10:14 AM
Last Modification Date:
2024-10-26 @ 12:26 PM
Study NCT ID:
NCT03194893
Status:
RECRUITING
Last Update Posted:
2024-07-11
First Post:
2017-06-20
Brief Title:
A Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase ALK-Positive or Rearranged During Transfection RET-Positive Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche